Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Photodynamic augmentation of oncolytic virus therapy for central nervous system malignancies.
Shimizu K, Kahramanian A, Jabbar MADA, Turna Demir F, Gokyer D, Uthamacumaran A, Rajan A, Saad MA, Gorham J, Wakimoto H, Martuza RL, Rabkin SD, Hasan T, Wakimoto H. Shimizu K, et al. Among authors: wakimoto h. Cancer Lett. 2023 Sep 28;572:216363. doi: 10.1016/j.canlet.2023.216363. Epub 2023 Aug 22. Cancer Lett. 2023. PMID: 37619813 Free PMC article.
PTEN potentiation of oncolytic HSV therapy for glioblastoma.
Migliarese C, Wakimoto H. Migliarese C, et al. Among authors: wakimoto h. Mol Ther Oncolytics. 2023 Jun 2;29:143-144. doi: 10.1016/j.omto.2023.05.005. eCollection 2023 Jun 15. Mol Ther Oncolytics. 2023. PMID: 37313454 Free PMC article. No abstract available.
Editorial: Recent advances in oncolytic virus therapy for brain tumors.
Askari FS, Mohebbi A, Ning J, Kurozumi K, Wakimoto H. Askari FS, et al. Among authors: wakimoto h. Front Cell Infect Microbiol. 2023 Aug 17;13:1271559. doi: 10.3389/fcimb.2023.1271559. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37662010 Free PMC article. No abstract available.
Loss of methylthioadenosine phosphorylase immunoreactivity correlates with poor prognosis and elevated uptake of 11C-methionine in IDH-mutant astrocytoma.
Yamamura T, Tamura K, Kobayashi D, Inaji M, Toyama Y, Wakimoto H, Kiyokawa J, Hara S, Tanaka Y, Nariai T, Shimizu K, Ishii K, Maehara T. Yamamura T, et al. Among authors: wakimoto h. J Neurooncol. 2024 Jun;168(2):355-365. doi: 10.1007/s11060-024-04661-y. Epub 2024 Apr 1. J Neurooncol. 2024. PMID: 38557927
Tandem chimeric antigen receptor (CAR) T cells targeting EGFRvIII and IL-13Rα2 are effective against heterogeneous glioblastoma.
Schmidts A, Srivastava AA, Ramapriyan R, Bailey SR, Bouffard AA, Cahill DP, Carter BS, Curry WT, Dunn GP, Frigault MJ, Gerstner ER, Ghannam JY, Kann MC, Larson RC, Leick MB, Nahed BV, Richardson LG, Scarfò I, Sun J, Wakimoto H, Maus MV, Choi BD. Schmidts A, et al. Among authors: wakimoto h. Neurooncol Adv. 2022 Dec 22;5(1):vdac185. doi: 10.1093/noajnl/vdac185. eCollection 2023 Jan-Dec. Neurooncol Adv. 2022. PMID: 36751672 Free PMC article.
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma.
Spitzer A, Gritsch S, Nomura M, Jucht A, Fortin J, Raviram R, Weisman HR, Gonzalez Castro LN, Druck N, Chanoch-Myers R, Lee JJY, Mylvaganam R, Lee Servis R, Fung JM, Lee CK, Nagashima H, Miller JJ, Arrillaga-Romany I, Louis DN, Wakimoto H, Pisano W, Wen PY, Mak TW, Sanson M, Touat M, Landau DA, Ligon KL, Cahill DP, Suvà ML, Tirosh I. Spitzer A, et al. Among authors: wakimoto h. Cancer Cell. 2024 May 13;42(5):904-914.e9. doi: 10.1016/j.ccell.2024.03.008. Epub 2024 Apr 4. Cancer Cell. 2024. PMID: 38579724 Free article.
Exomap1 mouse: a transgenic model for in vivo studies of exosome biology.
Fordjour FK, Abuelreich S, Hong X, Chatterjee E, Lallai V, Ng M, Saftics A, Deng F, Carnel-Amar N, Wakimoto H, Shimizu K, Bautista M, Phu TA, Vu NK, Geiger PC, Raffai RL, Fowler CD, Das S, Christenson LK, Jovanovic-Talisman T, Gould SJ. Fordjour FK, et al. Among authors: wakimoto h. bioRxiv [Preprint]. 2023 May 29:2023.05.29.542707. doi: 10.1101/2023.05.29.542707. bioRxiv. 2023. PMID: 37398219 Free PMC article. Preprint.
308 results